Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pirfenidone”

132 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 132 results

Testing effectiveness (Phase 2)Study completedNCT01417156
What this trial is testing

Safety and PK Study of BIBF 1120 in Japanese Patients With IPF: Follow up Study From 1199.31(NCT01136174)

Who this might be right for
Pulmonary Fibrosis
Boehringer Ingelheim 20
Early research (Phase 1)Study completedNCT06569381
What this trial is testing

Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions

Who this might be right for
Idiopathic Pulmonary Fibrosis
Overseas Pharmaceuticals, Ltd. 18
Not applicableApproved For MarketingNCT02141087
What this trial is testing

Expanded Access Program (EAP): Allow Patients in the US With Idiopathic Pulmonary Fibrosis Access to Pirfenidone

Who this might be right for
Idiopathic Pulmonary Fibrosis
Genentech, Inc.
Early research (Phase 1)Study completedNCT07229716
What this trial is testing

Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects

Who this might be right for
Pulmonary Fibrosis
Guangdong Hengrui Pharmaceutical Co., Ltd 20
Not applicableStudy completedNCT04653831
What this trial is testing

Treatment With Pirfenidone for COVID-19 Related Severe ARDS

Who this might be right for
Covid19ARDS
Soroka University Medical Center 26
Early research (Phase 1)Study completedNCT03315741
What this trial is testing

The Safety and Tolerability of Pirfenidone for BOS After HCT

Who this might be right for
Bronchiolitis ObliteransGraft Vs Host Disease
Stanford University 30
Post-approval studies (Phase 4)UnknownNCT04928586
What this trial is testing

Immunosuppressant Combined With Pirfenidone in CTD-ILD

Who this might be right for
PirfenidoneConnective Tissue DiseasesInterstitial Lung Disease
Qilu Hospital of Shandong University 200
Early research (Phase 1)Study completedNCT04971746
What this trial is testing

Drug-drug Interaction Study with GLPG4716 and Nintedanib and Pirfenidone in Healthy Subjects

Who this might be right for
Healthy
Lakefront Biotherapeutics NV 58
Early research (Phase 1)UnknownNCT05280873
What this trial is testing

Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP

Who this might be right for
PneumonitisMalignant Tumor
Zhou Chengzhi 48
Early research (Phase 1)Not Yet RecruitingNCT07654517
What this trial is testing

A Phase I Evaluation of the Safety and Tolerability of Pirfenidone in Idiopathic Subglottic Stenosis

Who this might be right for
Idiopathic Subglottic StenosisSubglottic Stenosis (SGS)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 40
Early research (Phase 1)Study completedNCT04888715
What this trial is testing

To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy Volunteers

Who this might be right for
Idiopathic Pulmonary Fibrosis
Daewoong Pharmaceutical Co. LTD. 48
Testing effectiveness (Phase 2)Study completedNCT03099187
What this trial is testing

Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung Disease

Who this might be right for
Lung Diseases, Interstitial
Hoffmann-La Roche 253
Post-approval studies (Phase 4)Study completedNCT03939520
What this trial is testing

Management of Progressive Disease in Idiopathic Pulmonary Fibrosis

Who this might be right for
Progressive Idiopathic Pulmonary Fibrosis
Hospices Civils de Lyon 279
Early research (Phase 1)Study completedNCT05428150
What this trial is testing

Randomized, Crossover, Multi-Dose Pharmacokinetics of EXCL-100 Pirfenidone-Sustained Release Tablet and Esbriet in Healthy Volunteers

Who this might be right for
Idiopathic Pulmonary Fibrosis
Excalibur Pharmaceuticals, Inc. 32
Post-approval studies (Phase 4)Study completedNCT02598193
What this trial is testing

Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 89
Large-scale testing (Phase 3)UnknownNCT04282902
What this trial is testing

Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection

Who this might be right for
Novel Coronavirus PneumoniaPneumoniaPirfenidone
Huilan Zhang 294
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07268677
What this trial is testing

A Single-arm Clinical Study Evaluating Pirfenidone and Sintilimab in Combination With Standard Neoadjuvant Chemotherapy for Colorectal Cancer Patients With Peritoneal Metastasis.

Who this might be right for
Colorectal Cancer
Guoxiang Cai 30
Testing effectiveness (Phase 2)Study completedNCT02932566
What this trial is testing

The Efficacy and Safety of Pirfenidone in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction

Who this might be right for
Cardiac Failure
Manchester University NHS Foundation Trust 129
Not applicableUnknownNCT05133453
What this trial is testing

Pirfenidone Use in Asbestosis Patients: Efficacy and Prognosis

Who this might be right for
Asbestosis
Cairo University 40
Testing effectiveness (Phase 2)Study completedNCT04675619
What this trial is testing

Evaluation of the Efficacy of Pirfenidone in Progressive Chronic Hypersensitivity Pneumonitis

Who this might be right for
Hypersensitivity Pneumonitis
Zagazig University 40
Next Page